Variant report
Variant | nsv1021807 |
---|---|
Chromosome Location | chr5:113938442-114005137 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:64)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:3 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TRIM36-4 | chr5:114004040-114004103 | ENSG00000246316.3 |
2 | lnc-TRIM36-4 | chr5:113998658-113998922 | ENSG00000246316.3 |
3 | lnc-TRIM36-4 | chr5:114003306-114003444 | ENSG00000246316.3 |
4 | lnc-TRIM36-4 | chr5:114003805-114003928 | ENSG00000246316.3 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000246316 | TF binding region |
ENSG00000212195 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553138180 | chr5:113938462-113938463 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183787024 | chr5:113938465-113938466 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs74965754 | chr5:113938468-113938469 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186869760 | chr5:113938483-113938484 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541713538 | chr5:113938488-113938489 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556860161 | chr5:113938497-113938498 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575062867 | chr5:113938560-113938561 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545627533 | chr5:113938567-113938568 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563819525 | chr5:113938579-113938580 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528224539 | chr5:113938616-113938617 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370622754 | chr5:113938622-113938623 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144989217 | chr5:113938623-113938624 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142947576 | chr5:113938636-113938637 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140241186 | chr5:113938649-113938650 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79234343 | chr5:113938660-113938661 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112757459 | chr5:113938672-113938673 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146924662 | chr5:113938696-113938697 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570769769 | chr5:113938708-113938709 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548870549 | chr5:113938710-113938711 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570376703 | chr5:113938731-113938732 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534763621 | chr5:113938741-113938742 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531107990 | chr5:113938743-113938744 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552832065 | chr5:113938750-113938751 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115243206 | chr5:113938751-113938752 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534845832 | chr5:113938757-113938758 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs137939153 | chr5:113938796-113938797 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532051388 | chr5:113971018-113971019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146857710 | chr5:113971039-113971040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376996113 | chr5:113971041-113971042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570879816 | chr5:113971055-113971056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140269948 | chr5:113971056-113971057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542135772 | chr5:113971106-113971107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370734731 | chr5:113971121-113971122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150324676 | chr5:113971134-113971135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375362912 | chr5:113971171-113971172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs137864909 | chr5:113971194-113971195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186817797 | chr5:113971209-113971210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564123307 | chr5:113971227-113971228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs386691328 | chr5:113971241-113971242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78818346 | chr5:113971242-113971243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547627754 | chr5:113971270-113971271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375569442 | chr5:113971286-113971287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149455241 | chr5:113971312-113971313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548895634 | chr5:113971327-113971328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570149741 | chr5:113971329-113971330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143052116 | chr5:113971331-113971332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558737978 | chr5:113971337-113971338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368277348 | chr5:113971351-113971352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534813833 | chr5:113971367-113971368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552927230 | chr5:113971378-113971379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:113938400-113938800 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
2 | chr5:113971000-113972200 | Enhancers | Colon Smooth Muscle | Colon |
3 | chr5:113980000-113980600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr5:113980400-113981000 | Enhancers | Brain Substantia Nigra | brain |
5 | chr5:113985200-113986200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr5:113985800-113986200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr5:113992800-113994800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr5:113993400-113994200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr5:113993400-113994800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr5:113993600-113994000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr5:113994800-113996800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr5:113997000-113997200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr5:114001000-114001600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr5:114001000-114001800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |